These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 17368226)

  • 1. Gut microbiota: mining for therapeutic potential.
    O'Hara AM; Shanahan F
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):274-84. PubMed ID: 17368226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
    Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular interactions between bacteria, the epithelium, and the mucosal immune system in the intestinal tract: implications for chronic inflammation.
    Clavel T; Haller D
    Curr Issues Intest Microbiol; 2007 Sep; 8(2):25-43. PubMed ID: 17542334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease.
    Shanahan F
    Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G417-21. PubMed ID: 15701620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease, gut bacteria and probiotic therapy.
    Reiff C; Kelly D
    Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evidence for immunomodulatory effects of probiotic bacteria.
    Ruemmele FM; Bier D; Marteau P; Rechkemmer G; Bourdet-Sicard R; Walker WA; Goulet O
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):126-41. PubMed ID: 19179874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics in inflammatory bowel disease--therapeutic rationale and role.
    Shanahan F
    Adv Drug Deliv Rev; 2004 Apr; 56(6):809-18. PubMed ID: 15063591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The normal intestinal microbiota.
    Marchesi J; Shanahan F
    Curr Opin Infect Dis; 2007 Oct; 20(5):508-13. PubMed ID: 17762785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota.
    Elson CO; Cong Y; McCracken VJ; Dimmitt RA; Lorenz RG; Weaver CT
    Immunol Rev; 2005 Aug; 206():260-76. PubMed ID: 16048554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the innate immune system in the pathogenesis of inflammatory bowel disease.
    van Lierop PP; Samsom JN; Escher JC; Nieuwenhuis EE
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):142-51. PubMed ID: 19179875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the role of the metabolic activity of the gut microbiota in inflammatory bowel disease? Probing for answers with stable isotopes.
    Barclay AR; Morrison DJ; Weaver LT
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):486-95. PubMed ID: 18493202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial influences in inflammatory bowel diseases.
    Sartor RB
    Gastroenterology; 2008 Feb; 134(2):577-94. PubMed ID: 18242222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria?
    Blum S; Schiffrin EJ
    Curr Issues Intest Microbiol; 2003 Sep; 4(2):53-60. PubMed ID: 14503689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The intestinal microbiota and inflammatory bowel disease].
    Guarner F
    Gastroenterol Hepatol; 2011 Mar; 34(3):147-54. PubMed ID: 21377761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-bacteria interaction in inflammatory bowel disease.
    Knight P; Campbell BJ; Rhodes JM
    Br Med Bull; 2008; 88(1):95-113. PubMed ID: 18931057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.
    Yu CG; Huang Q
    J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intestinal flora in inflammatory bowel disease: normal or abnormal?
    Guarner F
    Curr Opin Gastroenterol; 2005 Jul; 21(4):414-8. PubMed ID: 15930980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-bacterial interactions in inflammatory bowel disease.
    Mahida YR; Rolfe VE
    Clin Sci (Lond); 2004 Oct; 107(4):331-41. PubMed ID: 15212627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota-stimulated immune mechanisms to maintain gut homeostasis.
    Chung H; Kasper DL
    Curr Opin Immunol; 2010 Aug; 22(4):455-60. PubMed ID: 20656465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the modulation of microbiota on the gastrointestinal immune system and bowel function.
    Kanauchi O; Andoh A; Mitsuyama K
    J Agric Food Chem; 2013 Oct; 61(42):9977-83. PubMed ID: 24070265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.